Dow Up 0.28% Nasdaq Up 0.05%

Gilead Sciences Inc. (GILD)

-NasdaqGS
101.31 Up 0.03(0.03%) 1:25PM EDT - Nasdaq Real Time Price
Prev Close:101.28
Open:100.71
Bid:101.34 x 500
Ask:101.36 x 400
1y Target Est:111.43
Beta:1.01
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:100.70 - 102.57
52wk Range:57.31 - 102.57
Volume:6,887,545
Avg Vol (3m):11,520,400
Market Cap:153.15B
P/E (ttm):37.52
EPS (ttm):2.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 0.03%153.15B
GSKUp 0.60%114.42B
PFEDown 0.14%183.25B
RHHBYDown 0.28%248.28B

Key Statistics

Forward P/E (1 yr):10.84
P/S (ttm):8.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.00
Quarterly EPS Est (Sep-14) :1.89
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback